期刊文献+

抑癌基因FHIT和WWOX与前列腺癌相关性的初步研究 被引量:2

下载PDF
导出
摘要 目的:探讨FHIT和WWOXmRNA及其蛋白在前列腺癌及癌旁正常组织的表达,分析其与临床病理特征之间的相关性。方法:免疫组化法检测FHIT和WWOX蛋白在前列腺癌组织中表达;RT-PCR法检测FHIT和WWOXmRNA在前列腺癌及癌旁正常组织表达。结果:FHIT和WWOX蛋白表达在前列腺癌中与低分化组及高与低分化组间有统计学意义(P<0.05)。二者在分期中表达的缺失的差异都具有显著性(P<0.05)。FHITmRNA和WWOXmRNA的在前列腺癌的表达低于癌旁正常组织(P<0.05)。结论:FHIT与WWOX为抑癌基因,其表达与前列腺癌的发生发展具有相关性。
机构地区 佳木斯大学
出处 《黑龙江医药科学》 2015年第4期20-21,共2页 Heilongjiang Medicine and Pharmacy
基金 黑龙江省卫生厅科研项目 编号:2011-439 佳木斯大学科技重点项目 编号:Sz2011-009 黑龙江省普通高等学校青年学术骨干支持计划项目 编号:1252G059
  • 相关文献

参考文献8

  • 1胡存利,王超,牛文斌,郝鹏,郭玉刚,曹会峰,迟宝进.血清EPCA-2联合尿液PCA-3检测在前列腺癌诊断中的临床意义[J].黑龙江医药科学,2013,36(5):37-38. 被引量:11
  • 2韩旭,罗振国,杜丛林,吴旭鹏,夏星博,王雪.血清EPCA-2与FPSA/TPSA值在前列腺癌诊断的关系[J].黑龙江医药科学,2014,37(4):7-8. 被引量:5
  • 3Bednarek AK, Laf lin KJ, Daniel RL, et al. WWOX, a novel WW- domain - containing p rote in mapping to human chromo- some16q23.3 -24,1, a region frequent ly affect ed in breast cancer [J]. Cancer Res,2000, 60 (8) :2140 -2145.
  • 4Otha M, Inoue H, Cott icelli MG, et al. The FHIT gene, spanning the chromosome 3p 14,2 fragile site and renal carcinoma - asociated t (3 ;8 )b reakpoint, is abnormal in digest ive t tact cancers[ J ]. Cell, 1996,84 (4) :587-597.
  • 5Zaw aeka - Pankau J, Ferens B. Enlightened protein : Fhit tumor- suppressor protein structure and function and it s role in the toxicity of protoporphyrin IX - mediated photodynamie reaction [ J ]. Toxicol Appl Pharmaeo1,2009,241 (2) :246 - 252.
  • 6Bureke L, Khan MA, Freemann AN , et al. Allelie deleti on analysis of the FHIT gene predicts poor survival in non small cell lung cancer [J].CaneerRes, 1998, 58(12) :2533 -2536.
  • 7Cantor JP, Liopoulos SD, Rao AS ,et al. Eplgenetlemodulatlon of en- dogenous tumor suppressor expression in lung cancer xenograf ts sup- presses tumori geni city [ J ]. Int J Cancer,2007,120 ( 1 ) : 24 - 31.
  • 8Chang NS, Hsu LJ, Lin YS, et al. Oxidoreduet ase : A candidat etumor suppressor[ J]. T rends Mol Med,2007,13 ( 1 ) : 12 - 22.

二级参考文献13

  • 1Dhir R, Vietmeier B, Arlotti J, et al. Early identification of indi- viduals with prostate cancer in negative biopsies[J]. J Urol, 2004, 171(4) 1419-1423.
  • 2Brunagel G, Schoen RE, Bauer AJ, et al. Nuclear matrix protein alterations associated with colon cancer metastasis to the liverJ']. Clin Cancer Res, 2002,8(10) :3039-3045.
  • 3Getzenberg, Leman ES, Cannon GW, et al. EPCA-2: A Highly Specific Serum Marker for Prostate Gancer[-]-[. ] Urol, 2006,175 (4) :275-275.
  • 4Bussemakers M], Van BA, Verhaegh GW, et al. DD3: a new prostate- specific gene, highly overexpressed in prostate cancer [J. Cancer Res,1999,59:5975-5979.
  • 5de Kok JB, Verhaegh GW, Roelofs RW, et al. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors [J']. Cancer Res, 2002,62:2695-2698.
  • 6JemalA,SiegelR,Ward E,et al.Cancer statistics 2006[J].CA Cancer JClin,2006,56(2):106-130.
  • 7Pakin DM,Bray F,Ferlay J,et al.Global cancer statistics 2002[J].CA Cancer JClin,2005,55(2):74-108.
  • 8Rbert H,Getzenberg,Paul B,et al.Detection of Prostate Cancer with a Blood-Based Assay for Early Prostate Cancer Antigen[J].Cancer Res,2005,65:4097-4100.
  • 9王一,刘晓强,郭战军,孙光,吴长利,刘雨.PSA及F/T对中国人群前列腺癌早期诊断的系统评价[J].现代泌尿生殖肿瘤杂志,2009,1(5):263-267. 被引量:6
  • 10罗振国,蒲永昌,王天喜.尿液PCA3基因检测在前列腺癌诊断中的意义[J].黑龙江医药科学,2010,33(3):58-59. 被引量:5

共引文献14

同被引文献8

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部